An ethics framework for consolidating and prioritizing COVID-19 clinical trials is a research paper published in Clinical Trials (2021). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: UL1TR002240
National Center for Advancing Translational Sciences
Grant: UL1TR002319
National Center for Advancing Translational Sciences
Grant: UL1TR003098
National Center for Advancing Translational Sciences
Grant: UL1TR003142-01
National Institutes of Health
Grant: 5UL1TR002240-02
Michigan Institute for Clinical and Health Research (MICHR)
National Institutes of Health
Grant: 5UL1TR003142-03
Stanford Center for Clinical & Translational Education and Research (Spectrum)
National Institutes of Health
Grant: 3UL1TR002319-02S1
Transform Dissemination and Implementation Science in CTSA Programs
National Institutes of Health
Grant: 5UL1TR003098-02
Johns Hopkins Institute for Clinical and Translational Research
NCATS NIH HHS
Grant: UL1 TR003142
FWCI
3.77
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals